Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Idrx, Inc., A Wholly Owned Subsidiary Of Gsk, Llc

Clinical trials sponsored by Idrx, Inc., A Wholly Owned Subsidiary Of Gsk, Llc, explained in plain language.

Trials to join now! 1

New hope for tough gut tumors: first human trial launches

Disease control Recruiting now

This study tests a new drug, IDRX-42, for people with advanced gastrointestinal stromal tumors (GIST) that have spread or cannot be removed by surgery. The goal is to see if the drug is safe and can shrink or control these tumors. About 278 adults who have already tried the stand…

Phase: PHASE1 • Sponsor: IDRX, Inc., a wholly owned subsidiary of GSK, LLC • Aim: Disease control

Last updated May 26, 2026 07:56 UTC